A Randomized, Open-Label, Multicenter Trial for the Safety and Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial Infarction
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jun-Won | - |
dc.contributor.author | Lee, Seung-Hwan | - |
dc.contributor.author | Youn, Young-Jin | - |
dc.contributor.author | Ahn, Min-Soo | - |
dc.contributor.author | Kim, Jang-Young | - |
dc.contributor.author | Yoo, Byung-Su | - |
dc.contributor.author | Yoon, Junghan | - |
dc.contributor.author | Kwon, Woocheol | - |
dc.contributor.author | Hong, In-Soo | - |
dc.contributor.author | Lee, Kyounghoon | - |
dc.contributor.author | Kwan, Jun | - |
dc.contributor.author | Park, Keum Soo | - |
dc.contributor.author | Choi, Donghoon | - |
dc.contributor.author | Jang, Yang Soo | - |
dc.contributor.author | Hong, Mun K. | - |
dc.date.available | 2020-02-28T18:44:17Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-01 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12959 | - |
dc.description.abstract | Recent studies suggest that the intracoronary administration of bone marrow (BM)-derived mesenchymal stem cells (MSCs) may improve left ventricular function in patients with acute myocardial infarction (AMI). However, there is still argumentative for the safety and efficacy of MSCs in the AMI setting. We thus performed a randomized pilot study to investigate the safety and efficacy of MSCs in patients with AMI. Eighty patients with AMI after successful reperfusion therapy were randomly assigned and received an intracoronary administration of autologous BM-derived MSCs into the infarct related artery at 1 month. During follow-up period, 58 patients completed the trial. The primary endpoint was changes in left ventricular ejection fraction (LVEF) by single-photon emission computed tomography (SPECT) at 6 month. We also evaluated treatment-related adverse events. The absolute improvement in the LVEF by SPECT at 6 month was greater in the BM-derived MSCs group than in the control group (5.9% +/- 8.5% vs 1.6% +/- 7.0%; P= 0.037). There was no treatment-related toxicity during intracoronary administration of MSCs. No significant adverse cardiovascular events occurred during follow-up. In conclusion, the intracoronary infusion of human BM-derived MSCs at 1 month is tolerable and safe with modest improvement in LVEF at 6-month follow-up by SPECT. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.subject | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject | BONE-MARROW-CELLS | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | RAT MODEL | - |
dc.subject | TRANSPLANTATION | - |
dc.subject | QUANTIFICATION | - |
dc.subject | GUIDELINES | - |
dc.subject | SURVIVAL | - |
dc.subject | TRENDS | - |
dc.title | A Randomized, Open-Label, Multicenter Trial for the Safety and Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial Infarction | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000330508600004 | - |
dc.identifier.doi | 10.3346/jkms.2014.29.1.23 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.29, no.1, pp.23 - 31 | - |
dc.identifier.kciid | ART001844566 | - |
dc.identifier.scopusid | 2-s2.0-84907424372 | - |
dc.citation.endPage | 31 | - |
dc.citation.startPage | 23 | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 29 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Lee, Kyounghoon | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Mesenchymal Stem Cells | - |
dc.subject.keywordAuthor | Myocardial Infarction | - |
dc.subject.keywordAuthor | Ventricular Dysfunction | - |
dc.subject.keywordAuthor | Left | - |
dc.subject.keywordPlus | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject.keywordPlus | BONE-MARROW-CELLS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | RAT MODEL | - |
dc.subject.keywordPlus | TRANSPLANTATION | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | TRENDS | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.